On the public citation graph

Momordica Anti-Hiv Protein Map30 Abrogates the Persistent Infection of an Oncogenic Human Herpesvirus in Host Cells

https://doi.org/10.2139/ssrn.4448956
0 signed · 42 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/bjs.18004619704openalex-extracted
A sarcoma involving the jaws in african children
inferredcites →https://doi.org/10.1002/cncr.28418openalex-extracted
Epstein‐Barr virus nuclear antigen 1 (EBNA1) protein induction of epithelial‐mesenchymal transition in nasopharyngeal carcinoma cells
inferredcites →https://doi.org/10.1002/ijc.2910160114openalex-extracted
Production by EBV infection of an EBNA‐positive subline from an EBNA‐negative human lymphoma cell line without detectable EBV DNA
inferredcites →https://doi.org/10.1006/bbrc.1995.1405openalex-extracted
Potentiation of Anti-HIV Activity of Anti-inflammatory Drugs, Dexamethasone and Indomethacin, by MAP30, the Antiviral Agent from Bitter Melon
inferredcites →https://doi.org/10.1006/bbrc.1996.0334openalex-extracted
The Activity of Plant-Derived Antiretroviral Proteins MAP30 and GAP31 against Herpes Simplex Virus Infectionin Vitro
inferredcites →https://doi.org/10.1006/bbrc.1999.1213openalex-extracted
Proteolytic Fragments of Anti-HIV and Anti-tumor Proteins MAP30 and GAP31 Are Biologically Active
inferredcites →https://doi.org/10.1007/bf00571929openalex-extracted
An Epstein-Barr virus-producer line Akata: Establishment of the cell line and analysis of viral DNA
inferredcites →https://doi.org/10.1007/s00439-020-02145-3openalex-extracted
Genetic susceptibility to EBV infection: insights from inborn errors of immunity
inferredcites →https://doi.org/10.1007/s10120-021-01193-6openalex-extracted
EBNA1 inhibitors have potent and selective antitumor activity in xenograft models of Epstein–Barr virus-associated gastric cancer
inferredcites →https://doi.org/10.1007/s11033-007-9191-2openalex-extracted
Inhibition on Hepatitis B virus in vitro of recombinant MAP30 from bitter melon
inferredcites →https://doi.org/10.1007/s12026-014-8496-1openalex-extracted
The interplay between Epstein–Barr virus and B lymphocytes: implications for infection, immunity, and disease
inferredcites →https://doi.org/10.1007/springerreference_301423openalex-extracted
Epstein-Barr Virus Infection
inferredcites →https://doi.org/10.1016/0014-5793(90)80438-oopenalex-extracted
MAP 30: a new inhibitor of HIV‐1 infection and replication
inferredcites →https://doi.org/10.1016/0042-6822(77)90292-6openalex-extracted
Efficiency of transformation of lymphocytes by Epstein-Barr virus
inferredcites →https://doi.org/10.1016/0092-8674(95)90232-5openalex-extracted
Crystal structure of the DNA-binding domain of the Epstein-Barr virus origin-binding protein EBNA1
inferredcites →https://doi.org/10.1016/0378-1119(95)00186-aopenalex-extracted
Anti-HIV and anti-tumor activities of recombinant MAP30 from bitter melon
inferredcites →https://doi.org/10.1016/b978-0-12-374628-3.00035-9openalex-extracted
Health Benefits of Bitter Melon (Momordica charantia)
inferredcites →https://doi.org/10.1016/j.antiviral.2014.01.018openalex-extracted
Small molecule inhibition of Epstein–Barr virus nuclear antigen-1 DNA binding activity interferes with replication and persistence of the viral genome
inferredcites →https://doi.org/10.1016/j.antiviral.2019.02.015openalex-extracted
GAP31 from an ancient medicinal plant exhibits anti-viral activity through targeting to Epstein-Barr virus nuclear antigen 1
inferredcites →https://doi.org/10.1016/j.bbrc.2011.12.104openalex-extracted
EGCG debilitates the persistence of EBV latency by reducing the DNA binding potency of nuclear antigen 1
inferredcites →https://doi.org/10.1016/j.phrs.2020.105157openalex-extracted
MAP30 protein from Momordica charantia is therapeutic and has synergic activity with cisplatin against ovarian cancer in vivo by altering metabolism and inducing ferroptosis
inferredcites →https://doi.org/10.1016/j.toxicon.2004.05.003openalex-extracted
The history of ricin, abrin and related toxins
inferredcites →https://doi.org/10.1016/s0015-0282(99)00302-7openalex-extracted
The antiviral agents, MAP30 and GAP31, are not toxic to human spermatozoa and may be useful in preventing the sexual transmission of human immunodeficiency virus type 1
inferredcites →https://doi.org/10.1021/acschemneuro.1c00350openalex-extracted
Identification of Potential Inhibitors against Epstein–Barr Virus Nuclear Antigen 1 (EBNA1): An Insight from Docking and Molecular Dynamic Simulations
inferredcites →https://doi.org/10.1038/d41591-022-00061-9openalex-extracted
Finding a vaccine for Epstein-Barr virus
inferredcites →https://doi.org/10.1039/c6fo01812bopenalex-extracted
Momordica charantia: a popular health-promoting vegetable with multifunctionality
inferredcites →https://doi.org/10.1056/nejm200008173430707openalex-extracted
Epstein–Barr Virus Infection
inferredcites →https://doi.org/10.1073/pnas.1321800111openalex-extracted
Nucleolin is important for Epstein–Barr virus nuclear antigen 1-mediated episome binding, maintenance, and transcription
inferredcites →https://doi.org/10.1073/pnas.1525444113openalex-extracted
Ribosome Protein L4 is essential for Epstein–Barr Virus Nuclear Antigen 1 function
inferredcites →https://doi.org/10.1073/pnas.211556598openalex-extracted
Epstein–Barr virus nuclear antigen 1 activates transcription from episomal but not integrated DNA and does not alter lymphocyte growth
inferredcites →https://doi.org/10.1073/pnas.92.19.8818openalex-extracted
Inhibition of the integrase of human immunodeficiency virus (HIV) type 1 by anti-HIV plant proteins MAP30 and GAP31.
inferredcites →https://doi.org/10.1110/ps.9.1.138openalex-extracted
Anti‐HIV and anti‐tumor protein MAP30, a 30 kDa single‐strand type‐I RIP, shares similar secondary structure and β‐sheet topology with the A chain of ricin, a type‐II RIP
inferredcites →https://doi.org/10.1126/scitranslmed.aau5612openalex-extracted
Structure-based design of small-molecule inhibitors of EBNA1 DNA binding blocks Epstein-Barr virus latent infection and tumor growth
inferredcites →https://doi.org/10.1128/jvi.01046-17openalex-extracted
Structural and Functional Basis for an EBNA1 Hexameric Ring in Epstein-Barr Virus Episome Maintenance
inferredcites →https://doi.org/10.1128/jvi.01628-10openalex-extracted
Roscovitine Inhibits EBNA1 Serine 393 Phosphorylation, Nuclear Localization, Transcription, and Episome Maintenance
inferredcites →https://doi.org/10.1128/jvi.71.9.6611-6618.1997openalex-extracted
Epstein-Barr virus nuclear protein LP stimulates EBNA-2 acidic domain-mediated transcriptional activation
inferredcites →https://doi.org/10.1136/jclinpath-2019-205822openalex-extracted
Epstein-Barr virus (EBV) reactivation and therapeutic inhibitors
inferredcites →https://doi.org/10.1371/journal.ppat.1003084openalex-extracted
The Nuclear Chaperone Nucleophosmin Escorts an Epstein-Barr Virus Nuclear Antigen to Establish Transcriptional Cascades for Latent Infection in Human B Cells
inferredcites →https://doi.org/10.1371/journal.ppat.1004656openalex-extracted
To Be or Not IIb: A Multi-Step Process for Epstein-Barr Virus Latency Establishment and Consequences for B Cell Tumorigenesis
inferredcites →https://doi.org/10.1517/17460441.2010.524640openalex-extracted
Development of drugs for Epstein–Barr virus using high-throughputin silicovirtual screening
inferredcites →https://doi.org/10.2174/156652409789839071openalex-extracted
Ribosome Inactivating Proteins (RIPs) from Momordica charantia for Anti Viral Therapy
inferredcites →https://doi.org/10.3389/fimmu.2021.734471openalex-extracted
Epstein Barr Virus: Development of Vaccines and Immune Cell Therapy for EBV-Associated Diseases
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.